Related Experiment Video
Updated: Dec 24, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
Body fat indices and survival in immunotherapy-treated patients with cancer
Rachael M Orlandella1, Jennifer R Bail2, Michael Behring3
1Graduate Biomedical Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
Cancer
|April 15, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Survival Analysis
588
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
588
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
184
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
184

